Impaired Beta-cell Function in Lean Normotolerant Former Gestational Diabetic Women.
From: Metabolic Unit, Institute of Biomedical Engineering, CNR, Padua, Italy. tura@isib.cnr.it
European journal of clinical investigation
- Publish Date: Jan 2006
- ISSN: 0014-2972
- Volume: 36
- Issue: 1
- Pages: 22-8
- Medium: Print
- Language: English
- Citation (JAMA): Tura A, Mari A, Winzer C, et al. Impaired Beta-cell Function in Lean Normotolerant Former Gestational Diabetic Women.. Eur. J. Clin. Invest. Jan 2006;36:22-8
Abstract
BACKGROUND: Former gestational diabetes (fGDM) constitutes a risk condition for the development of Type 2 diabetes. Former gestational diabetes is often characterized by obesity and hyperglycaemia, which may be concomitant and independent risk factors. MATERIALS AND METHODS: To assess insulin sensitivity and beta-cell function in fGDM uncomplicated by obesity and hyperglycaemia, we studied 24 lean fGDM women and 23 control women matched for age (30.7 +/- 0.7 years, whole cohort), body mass index (22.2 +/- 0.3 kg m(-2)), and indistinguishable for plasma glucose both at fasting and at 120 min. Several insulin sensitivity and beta-cell function indices were computed: homeostasis model assessment insulin resistance index (HOMA-R), insulin sensitivity index derived from an oral glucose tolerance test (OGIS), insulinogenic index, other empirical indices of insulin secretion and beta-cell function, and indices obtained using a beta-cell model. RESULTS: Though the majority of indices, and in particular insulin sensitivity (HOMA-R: 1.35 +/- 0.13 vs. 1.65 +/- 0.14; OGIS: 492.7 +/- 6.3 vs. 496.4 +/- 9.4 mL min(-1) m(-2)), were not significantly different in the two groups, the beta-cell glucose sensitivity obtained by modelling analysis was lower in fGDM (108 +/- 14 vs. 165 +/- 22 pmol min(-1) m(-2) mM(-1), P = 0.031). CONCLUSIONS: Impairment of beta-cell glucose sensitivity may be an intrinsic risk factor in fGDM independently of obesity and hyperglycaemia. Furthermore, we have shown that modelling analysis, in contrast to the empirical parameters, may be able to detect early beta-cell alterations in fGDM women.
Mesh Headings (Keywords): Adult, Blood Glucose, C-Peptide, Diabetes, Gestational, Dose-Response Relationship, Drug, Female, Glucose Tolerance Test, Humans, Insulin, Insulin Resistance, Islets of Langerhans, Models, Biological, Pregnancy, Thinness
Check for Full Text / PubMed Unique Identifier (PMID): 16403006
This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.
Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.
The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.